A0A6D2XEN6 (A0A6D2XEN6_PANTR) Pan troglodytes (Chimpanzee)
Leukotriene A(4) hydrolase UniProtKBInterProInteractive Modelling
611 aa; Sequence (Fasta) ;
3 identical sequences: Homo sapiens: P09960, A0A140VK27; Pan troglodytes: H2Q6N3
It is possible new templates exist for this target since these models were created.
Available Structures
77 Experimental Structures
| Description | PDB ID | Oligo-state | Range | Seq id (%) | Ligands | |
|---|---|---|---|---|---|---|
| Crystal structure of human LTA4H mutant E271A in complex with LTA4 (crystal form II) | homo-3-mer | 99.83 | 3×ZN; 7×IMD; 3×DJ3; | |||
| [E296Q]LTA4H in complex with RSR substrate | monomer | 99.84 | 1×ZN; 1×YB; 1×ACY; 1×GOL; | |||
| Crystal structure of leukotriene a4 hydrolase in complex with 2-amino-N-[4-(phenylmethoxy)phenyl]-a… | monomer | 100 | 1×ZN; 1×YB; 1×ACT; 1×4BG; | |||
| Complex of human leukotriene A4 hydrolase with a hydroxamic acid inhibitor | monomer | 100 | 1×ZN; 3×YB; 1×IMD; 1×ACT; 1×HA2; | |||
| Leukotriene A4 Hydrolase Complexed with Inhibitor RB3040 | monomer | 100 | 1×ZN; 1×YB; 1×IMD; 1×BIR; | |||
| Leukotriene A4 hydrolase complexed with inhibitor RB3041 | monomer | 100 | 1×ZN; 1×YB; 1×PH0; 1×ACY; | |||
| Leukotriene A4 Hydrolase Complexed with KELatorphan | monomer | 100 | 1×ZN; 3×YB; 1×IMD; 1×KEL; 1×ACY; | |||
| STRUCTURE OF LEUKOTRIENE A4 HYDROLASE COMPLEXED WITH BESTATIN. | monomer | 100 | 1×ZN; 3×YB; 1×ACT; 1×BES; 1×IMD; | |||
| STRUCTURE OF [E271Q]LEUKOTRIENE A4 HYDROLASE | monomer | 99.84 | 1×ZN; 1×YB; 1×ACY; 1×IMD; | |||
| Crystal structure of leukotriene A4 hydrolase in complex with 4-amino-N-[4-(phenylmethoxy)phenyl]-b… | monomer | 100 | 1×ZN; 1×YB; 1×4BS; 1×IMD; | |||
| STRUCTURE OF LEUKOTRIENE A4 HYDROLASE D375N MUTANT | monomer | 99.84 | 1×BES; 1×ACT; 1×IMD; 1×YB; 1×ZN; | |||
| STRUCTURE OF [R563A] LEUKOTRIENE A4 HYDROLASE | monomer | 99.84 | 1×ZN; 1×YB; 1×IMD; 1×ACY; | |||
| [E296Q]LTA4H in complex with Arg-Ala-Arg substrate | monomer | 99.84 | 1×ZN; 2×YB; 1×IMD; | |||
| Crystal structure of leukotriene A4 hydrolase in complex with (2S)-2-amino-5-[[4-[(2S)-2-hydroxy-2-… | monomer | 100 | 1×ZN; 3×YB; 1×IMD; 1×4BU; | |||
| Crystal structure of human LTA4H mutant D375N in open conformation (crystal form II) | monomer | 99.84 | 1×ZN; | |||
| Crystal structure of human LTA4H mutant D375N in open conformation (crystal form I) | monomer | 99.84 | 1×ZN; | |||
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor sc57461A | monomer | 100 | 1×ZN; 8×YB; 2×CL; 3×IMD; 1×GOL; 1×28P; 1×ACT; | |||
| Crystal structure of human LTA4H mutant D375N in complex with LTA4 | monomer | 99.84 | 1×ZN; 2×YB; 2×ACY; 1×DJ3; | |||
| Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue and 4-(4-benzylphenyl)thiazol-2… | monomer | 100 | 1×ZN; 1×28T; 1×1V6; 2×YB; 2×ACY; | |||
| Human Leukotriene A4 Hydrolase in complex with Pro-Gly-Pro analogue | monomer | 100 | 1×ZN; 1×28T; 5×YB; 2×ACY; | |||
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor dimethyl(2- (4-phenoxyphenoxy… | monomer | 100 | 1×DP8; 1×ZN; 4×YB; 2×IMD; | |||
| Leukotriene A4 hydrolase in complex with 1-[2-(1H-indol-5-yloxy)ethyl]piperidine-4-carboxylic acid | monomer | 100 | 1×ZN; 1×YB; 1×58Z; 1×ACT; 2×IMD; | |||
| LTA4 hydrolase in complex with Compound11 | monomer | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×BGW; | |||
| Crystal structure of leukotriene a4 hydrolase in complex with (3S)-3-amino-4-oxo-4-[(4-phenylmethox… | monomer | 100 | 1×ZN; 1×YB; 1×ACT; 1×IMD; 1×4BO; | |||
| Substrate-dependent divergence of leukotriene A4 hydrolase aminopeptidase activity | monomer | 100 | 1×ZN; 1×N0Y; 1×28T; | |||
| Substrate-dependent divergence of leukotriene A4 hydrolase aminopeptidase activity | monomer | 100 | 1×ZN; 1×N0Y; | |||
| Leukotriene A4 hydrolase in complex with 4-(4-benzylphenyl)-oxazol-2-amine | monomer | 100 | 1×ZN; 4×YB; 4×ACT; 2×IMD; 1×OVO; 2×GOL; | |||
| Leukotriene A4 hydrolase in complex with 4-(4-Benzylphenyl)-selenazol-2-amine | monomer | 100 | 1×ZN; 3×YB; 4×ACT; 2×IMD; 1×OD6; 2×GOL; | |||
| Crystal structure of human LTA4H mutant E271A in complex with LTA4 (crystal form I) | monomer | 99.83 | 1×ZN; 2×YB; 1×DJ3; | |||
| LTA4 hydrolase in complex with compound 6(R) | monomer | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×WEE; | |||
| Human Leukotriene A4 Hydrolase complexed with ligand 4-(4-benzylphenyl)thiazol-2-amine | monomer | 100 | 1×ZN; 1×1V6; 4×YB; 3×ACT; | |||
| Structure of Human Leukotriene A4 Hydrolase in complex with inhibitor H1 | monomer | 100 | 1×ZN; 1×YB; 3×GOL; 2×ACT; 1×IMD; 1×SHH; | |||
| Leukotriene A4 Hydrolase complexed with inhibitor 1-[2-(4-benzylphenoxy)ethyl]pyrrolidine. | monomer | 100 | 1×ZN; 3×YB; 1×ACT; 1×IMD; 1×27P; | |||
| Leukotriene A4 hydrolase in complex with fragment N-(pyridin-3-ylmethyl)aniline | monomer | 100 | 1×ZN; 2×YB; 1×11X; 1×IMD; | |||
| LTA4 hydrolase in complex with fragment2 | monomer | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×RZK; | |||
| Leukotriene A4 hydrolase in complex with fragment 4-(4-fluorobenzoyl)pyridine | monomer | 100 | 1×ZN; 2×YB; 1×22F; 1×ACT; 1×IMD; | |||
| Leukotriene A4 hydrolase in complex with fragment 5-hydroxyindole and bestatin | monomer | 100 | 1×ZN; 3×YB; 1×5H1; 1×BES; 1×IMD; | |||
| LTA4 hydrolase (E297Q) mutant in complex with Pro-Gly-Pro peptide | monomer | 99.83 | 1×ZN; 1×ACT; 2×YB; 1×IMD; | |||
| Leukotriene A4 hydrolase in complex with fragments N-(pyridin-3-ylmethyl)aniline and acetate | monomer | 100 | 1×ZN; 1×YB; 1×11X; 2×ACT; 2×IMD; | |||
| LTA4 hydrolase in complex with compound2 | monomer | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×A1H3S; | |||
| LTA4 hydrolase in complex with CTX-4430 | monomer | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×A1H3T; | |||
| LTA4 hydrolase in complex with compound R(13) | monomer | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×RZB; | |||
| LTA4 hydrolase in complex with compound LYS006 | monomer | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×RZE; | |||
| Crystal structures of the Human leukotriene A4 Hydrolase complex with a potential inhibitor H7 | monomer | 100 | 1×B3N; 1×ZN; 1×YB; 1×ACY; 1×IMD; | |||
| Crystal Structure Analysis of the Human Leukotriene A4 Hydrolase | monomer | 100 | 1×YB; 1×ZN; 2×ACT; 3×IMD; 2×GOL; 2×ACY; | |||
| LTA4 hydrolase in complex with fragment1 | monomer | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×RZN; | |||
| Leukotriene A4 hydrolase in complex with dihydroresveratrol and bestatin | monomer | 100 | 1×ZN; 3×YB; 1×RE2; 1×BES; 1×ACT; 1×IMD; | |||
| LTA4 hydrolase in complex with compound 6(S) | monomer | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×WSL; | |||
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor captopril | monomer | 100 | 1×ZN; 1×X8Z; 5×YB; 1×ACY; 2×GOL; | |||
| Structure of human Leukotriene A4 hydrolase in complex with inhibitor 4AZ | monomer | 100 | 1×ZN; 3×YB; 1×ACT; 1×A4Z; | |||
| Apo structure of human Leukotriene A4 hydrolase | monomer | 100 | 1×ACT; 1×ZN; 6×YB; 3×IMD; | |||
| Leukotriene A4 Hydrolase complexed with inhibitor 4-[(2S)-2-{[4-(4-chlorophenoxy)phenoxy]methyl}pyr… | monomer | 100 | 1×ZN; 3×YB; 1×ACT; 1×IMD; 1×25P; 1×GOL; | |||
| Crystal structure of leukotriene a4 hydrolase in complex with N5-[4-(phenylmethoxy)phenyl]-L-glutam… | monomer | 100 | 1×ZN; 3×YB; 1×IMD; 1×4BQ; | |||
| Leukotriene A4 Hydrolase complexed with inhibitor N-[3-(4-benzylphenoxy)propyl]-N-methyl-beta-alani… | monomer | 100 | 1×ZN; 3×YB; 1×ACT; 1×IMD; 1×28P; | |||
| LTA4 hydrolase in complex with Compound15 | monomer | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×BGK; | |||
| Leukotriene A4 hydrolase in complex with resveratrol | monomer | 100 | 1×ZN; 1×YB; 1×STL; 1×ACT; 1×IMD; | |||
| LTA4 hydrolase in complex with compound 2(S) | monomer | 100 | 1×ZN; 1×ACT; 2×YB; 2×IMD; 1×WID; | |||
| Leukotriene A4 hydrolase in complex with fragment 5-chloroindole and bestatin | monomer | 100 | 1×ZN; 3×YB; 1×11S; 1×BES; 1×IMD; | |||
| Leukotriene A4 hydrolase in complex with fragment 5-fluoroindole and bestatin | monomer | 100 | 1×ZN; 3×YB; 1×14O; 1×BES; 1×IMD; | |||
| The effect of modifier structure on the activation of leukotriene A4 hydrolase aminopeptidase activ… | monomer | 100 | 1×LNJ; 1×ZN; | |||
| LTA4 hydrolase in complex with compound3 | monomer | 100 | 1×ZN; 1×ACT; 3×YB; 2×IMD; 1×A1H3U; | |||
| Leukotriene A4 hydrolase in complex with {4-[(2R)-pyrrolidin-2-ylmethoxy]phenyl}(4-thiophen-3-ylphe… | monomer | 100 | 1×ZN; 1×YB; 1×798; 1×ACT; 2×IMD; | |||
| Leukotriene A4 Hydrolase complexed with inhibitor (2R)-2-[(4-benzylphenoxy)methyl]pyrrolidine. | monomer | 100 | 1×ZN; 2×YB; 1×ACT; 2×IMD; 1×24P; 1×GOL; | |||
| Leukotriene A4 hydrolase in complex with dihydroresveratrol | monomer | 100 | 1×ZN; 1×YB; 1×RE2; 1×ACT; 1×IMD; | |||
| Leukotriene A4 hydrolase in complex with 5-[2-(1H-pyrrol-1-yl)ethoxy]-1H-indole | monomer | 100 | 1×ZN; 1×YB; 1×00G; 1×ACT; 2×IMD; | |||
| Leukotriene A4 hydrolase in complex with fragment 2-(pyridin-3-ylmethoxy)aniline | monomer | 100 | 1×ZN; 1×YB; 1×848; 3×ACT; 2×IMD; | |||
| Leukotriene A4 hydrolase in complex with fragment 4-(2-amino-1,3-thiazol-4-yl)phenol | monomer | 100 | 1×ZN; 1×YB; 2×92G; 2×ACT; 2×IMD; | |||
| Leukotriene A4 hydrolase in complex with fragment (4-thiophen-2-ylphenyl)methanamine | monomer | 100 | 1×ZN; 1×YB; 1×80G; 2×ACT; 2×IMD; | |||
| Leukotriene A4 hydrolase in complex with fragment 3-(benzyloxy)pyridin-2-amine | monomer | 100 | 1×ZN; 1×YB; 1×3IP; 3×ACT; 2×IMD; | |||
| Leukotriene A4 hydrolase in complex with N-benzyl-4-[(2R)-pyrrolidin-2-ylmethoxy]aniline | monomer | 100 | 3×YB; 1×ZN; 1×812; 1×IMD; | |||
| Leukotriene A4 hydrolase in complex with N-methyl-1-(2-thiophen-2-ylphenyl)methanamine | monomer | 100 | 1×ZN; 1×YB; 1×692; 1×ACT; 2×IMD; | |||
| Crystal structure of LTA4H bound to a selective inhibitor against LTB4 generation | monomer | 100 | 1×ZN; 1×YB; 1×IMD; 1×8KW; 1×ACT; | |||
| Leukotriene A4 hydrolase in complex with (5-thiophen-2-ylthiophen-2-yl)methylamine | monomer | 100 | 1×ZN; 1×YB; 1×492; 1×ACT; 2×IMD; | |||
| Crystal structure of human LTA4H mutant R563A in open conformation | monomer | 99.83 | 1×ZN; | |||
| Synthesis and Evaluation of Diaryl Ether Modulators of the Leukotriene A4 Hydrolase Aminopeptidase … | monomer | 100 | 1×VI7; 1×ZN; | |||
| Leukotriene A4 hydrolase in complex with (R)-pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanol | monomer | 100 | 1×ZN; 1×YB; 1×80A; 1×ACT; 2×IMD; | |||
| Leukotriene A4 hydrolase in complex with pyridin-4-yl[4-(2-pyrrolidin-1-ylethoxy)phenyl]methanone | monomer | 100 | 1×ZN; 1×YB; 1×52D; 2×IMD; | |||
1 SWISS-MODEL model
| Template | Oligo-state | QMEAN | Range | Ligands | Trg-Tpl Seq id (%) | |
|---|---|---|---|---|---|---|
| 3cho.1.A | monomer | 0.92 | 1×ZN; 1×4BG; | 100.00 | ||